Glasses & Contact Lens Manufacturing in European Union 2026: Industry Statistics & Trends

The glasses and contact lens manufacturing industry in the European Union involves the fabrication of corrective spectacle lenses, contact lenses, ophthalmic frames, and protective eyewear. The sector is transitioning from traditional manufacturing toward advanced optical medtech and tech-integrated eyewear, as demonstrated by the rapid commercialization of smart audio/AI glasses. Financial performance remains robust with leading multinational operators reporting record net sales, such as EssilorLuxottica SA's global consolidated revenue of EUR 28,491 million in 2025 (EssilorLuxottica Q4 FY 2025 Financial Release) and Safilo Group S.p.A.'s net sales of EUR 983.4 million in 2025 (Safilo Group

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Glasses & Contact Lens Manufacturing in European Union industry cover?

The industry comprises the manufacturing of ophthalmic goods designed for vision correction and ocular protection. Key products manufactured include contact lenses, single-focal and progressive spectacle lenses made of plastic or glass, spectacle frames and mountings, and finished spectacles or protective goggles. The scope excludes the retail-level grinding of lenses and ophthalmic optical instruments used primarily by practitioners.

• •Covers the fabrication of finished corrective spectacles, sunglasses, safety goggles, and contact lenses under NACE economic classification.
• •Includes upstream processes such as lens polishing, precision grinding, and specialized anti-reflective, scratch-resistant, or UV-protective coatings.
• •Encompasses both high-volume standardized contact lens molding and bespoke prescription-based glass or polymer lens surfacing.

Who operates in the industry and how is it structured?

The European Union market features a highly integrated tier of multinational operators that control extensive global supply chains, alongside specialized regional manufacturers. Operations are concentrated heavily in historic eyewear clusters, notably in the Veneto region of Italy and specialized hubs in France and Germany. These operators manufacture both proprietary house brands and licensed luxury fashion eyewear portfolios.

• •Production is anchored by large industrial complexes executing automated, micron-level CNC machining for lens fabrication.
• •A dual-operating model is common, where manufacturers license high-end fashion brands (e.g., Armani, Dior) while producing their own proprietary brands.
• •Sub-contracted specialized industrial operations form a vital support layer, representing a minor but essential share of the EU's total medical and optical device production value.

What drives demand in the industry?

Demand is primarily driven by demographic aging within the European population, which increases the prevalence of presbyopia and other age-related vision conditions. Rising awareness of ophthalmic health, combined with a growing global incidence of myopia among younger demographics, sustains consistent volumes for corrective products. Additionally, consumer demand is heavily influenced by fashion cycles and the rapid adoption of tech-integrated smart wearables.

• •Myopia management portfolios are expanding rapidly, with EssilorLuxottica reporting a 22% worldwide revenue growth in these specialized products in 2025.
• •Premium brand positioning and high-margin luxury frames continue to drive value growth in core Western European markets.
• •Increased screen time across all age groups acts as a primary catalyst for prescription lenses designed with specialized blue-light filtration.

Who are the notable companies in the industry?

The competitive landscape is dominated by a small number of public multinationals with deep vertical integration across manufacturing, research and development, and direct-to-consumer distribution. These market leaders compete on technological innovation, proprietary lens designs, and exclusive luxury brand licenses. Middle-tier operators focus on specific sub-segments such as premium designer frames, contract manufacturing, or protective eyewear.

• •EssilorLuxottica SA is the global and European market leader, reporting consolidated annual revenues of EUR 28,491 million in 2025.
• •Safilo Group S.p.A., a major Italian eyewear manufacturer, reported net sales of EUR 983.4 million in 2025, with European sales reaching EUR 423.9 million.
• •Carl Zeiss Meditec AG / Carl Zeiss AG and GrandVision (subsidiary of EssilorLuxottica) operate highly specialized optical and lens manufacturing divisions within Europe.
• •Inspecs Group plc is an active European competitor engaged in the design, manufacture, and distribution of ophthalmic frames and lenses.

What are the recent trends and outlook?

The industry is experiencing an accelerated convergence with consumer technology, driven by the commercial success of artificial intelligence and audio-enabled smart glasses. This shift is turning traditional eyewear manufacturers into medtech and consumer technology pioneers. At the same time, companies are restructuring supply chains to mitigate global tariff pressures and volatile transport costs.

• •The smart wearables sector accelerated in 2025, propelled by products like the Ray-Ban Meta and Oakley Meta smart glasses, exceeding 7 million units sold globally in 2025.
• •Strategic medtech transformations are underway, featuring the integration of advanced audiology and miniature acoustics directly into spectacle frames.
• •European manufacturers are increasingly optimizing regional production facilities in Europe to shield operations from transatlantic import tariffs.

How is the industry regulated?

Ophthalmic manufacturing in the EU is governed by stringent medical and consumer safety regulations. Corrective spectacles and contact lenses are classified as medical devices, subjecting manufacturers to strict safety, performance, and traceability criteria. Frame manufacturers must also comply with chemical safety guidelines regarding materials that come into prolonged contact with human skin.

• •Manufacturers must comply with the European Union Medical Device Regulation (MDR) 2017/745, which mandates rigorous clinical evaluations and post-market oversight.
• •Products sold in the European Economic Area must bear the CE mark, indicating conformity with EU safety, health, and environmental protection standards.
• •Raw materials used in frames, particularly plastics and metals, must comply with the EU REACH regulation to prevent the use of hazardous substances like nickel and lead.

Government, statistical and trade sources used for this Claight analysis.

• EssilorLuxottica Q4 FY 2025 Press Release (2026) ·
• Safilo Group Q4 and Full-Year 2025 Financial Results (2026) ·
• Eurostat Statistical Classification of Economic Activities in the European Community NACE Rev. 2 (2025)